商業用不動産ファンド、迅速な感染診断のためのバイオテクノロジー作成、XNUMXつの投資機会!ブログ
investment $500. InSitu 生物製剤 - Closing soon. Emerging Biotech company focusing ... non-opiate, non-addictive painkiller. The InSitu 生物製剤 offer is closing soon. Minimum ...
investment $500. InSitu 生物製剤 - Closing soon. Emerging Biotech company focusing ... non-opiate, non-addictive painkiller. The InSitu 生物製剤 offer is closing soon. Minimum ...
a maximum of $30 mill. InSitu 生物製剤 インサイツ 生物製剤 新たに登場しているのは…
of an annual $90 billion market opportunity. InSitu 生物製剤' focus ... of shares is nearly sold out. InSitu 生物製剤 is accepting a limited amount of investments at $6.90 per share. *Due to the demand for InSitu 生物製剤' ストック、 ...
& 生物学, the official journal of WMIS. Dr. Moore holds a PhD in Bioorganic ... 生物学, genetics, and tumor 生物学 and therapy. She developed the core ... (small-molecule/生物製剤/nucleic acid-based) and Biomarker Development; (Companion) Diagnostics (IVD, ...
in InSitu 生物製剤' AnestaGel™, a patented non-opioid pain relief drug ... will then receive a private invitation to invest from InSitu 生物製剤 ...
and improvements Check out Golf Suites 1 InSitu 生物製剤 - Anyone can invest ...
unit price. Insitu 生物製剤 Completed Their Raise to fund AnestaGel™, ...
in InSitu 生物製剤「AnestaGel™、非オピオイド鎮痛薬ベース...
investment $500. InSitu 生物製剤 - Max raise $10mill. Anyone can invest ...
兌換紙幣は年率 10% を支払います。 最低投資額 $10,000